Why Diligent?
Pharmaceutical and biotechnology trial sponsors as well as clinical trial service providers need Diligent’s centralized model to cut the cost and time of vendor qualification, achieve efficiency and eliminate redundancies:
- The average total cycle time from an RFI request to a signed contract is over 19 weeks
- Cycle times for vendor qualification are lengthy and growing
- Estimated industry spend on vendor qualification and requalification is $375m/year
Source: The Tufts/Avoca Benchmarking Study on Industry Qualification Practices, January 2020
- Higher compliance
- Faster vendor onboarding
- Greater efficiency and cost savings
- Better risk-based vendor selection
- Drive internal efficiency
- Reduce time to contract
- Showcase innovative services
- Improve risk awareness
- Avoid high costs
- Drive internal efficiency
See how the Diligent Qualification Platform works in 2 minutes with our CEO and Founder, Patty Leuchten:
Helping clinical trials start faster with streamlined selection & qualification of clinical research service providers
A Risk-Based Approach to Vendor Qualification and Management
A Practical Guide to Clinical Trial Sponsors
Register here